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Summary. We conduct a quasi-Monte-Carlo comparison of the recent developments in para-
metric and semiparametric regression methods for healthcare costs, both against each other
and against standard practice. The population of English National Health Service hospital
in-patient episodes for the financial year 2007–2008 (summed for each patient) is randomly
divided into two equally sized subpopulations to form an estimation set and a validation set.
Evaluating out-of-sample using the validation set, a conditional density approximation estima-
tor shows considerable promise in forecasting conditional means, performing best for accuracy
of forecasting and among the best four for bias and goodness of fit. The best performing model
for bias is linear regression with square-root-transformed dependent variables, whereas a gen-
eralized linear model with square-root link function and Poisson distribution performs best in
terms of goodness of fit. Commonly used models utilizing a log-link are shown to perform badly
relative to other models considered in our comparison.
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1. Introduction
The distribution of healthcare costs provides many challenges to the applied researcher: values
are non-negative (often with many observations with costs of 0), heteroscedastic, positively
skewed and leptokurtic. Although these, or similar, challenges are found within many areas of
empirical economics, the large interest inmodelling healthcare costs has driven the development
of an expanding array of estimation approaches and provides a natural context to compare
methods for handling heavy-tailed and non-normal distributions. For an excellent review of
statistical methods for the analysis of healthcare cost data with an emphasis on data collected
alongside randomized trials, see Mihaylova et al. (2011). Econometric models of healthcare
costs include applications to risk adjustment in insurance schemes (Van de Ven and Ellis, 2000),
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in devolving budgets to healthcare providers (e.g. Dixon et al. (2011)), in studies calculating
attributable healthcare costs to specific health factors or conditions (Johnson et al., 2003;Cawley
and Meyerhoefer, 2012) and in identifying treatment costs in health technology assessments
(Hoch et al., 2002).
In attempting to capture the complex distribution of healthcare costs, two broad modelling
approaches have been pursued. The first consists of flexible parametric models—distributions
such as the three-parameter generalized gamma and the four-parameter generalized beta of the
second kind distributions. This approach is attractive because of the range of distributions that
these models encompass, whereas models with fewer parameters are inherently more restrictive,
especially in regard to the assumptions that they impose on higher moments of the distribution
(e.g. skewness and kurtosis). The second is the use of semiparametric models including extended
estimating equations (EEEs), finite mixture models and conditional density approximation
estimators. The EEE model adopts the generalized linear models (GLMs) framework and al-
lows for the link and distribution functions to be estimated from data, rather than specified
a priori. Finitemixturemodels introduce heterogeneity (both observed andunobserved) through
mixtures of distributions. Conditional density approximation estimators are implemented by
dividing the empirical distribution into discrete intervals and then decomposing the conditional
density function into ‘discrete hazard rates’. Despite the burgeoning availability of healthcare
costs data via administrative records, together with an increased necessity for policy makers
to understand the determinants of healthcare costs and more, it is surprising that no previous
study compares comprehensively the models belonging to these two strands of literature. In this
paper we compare these approaches both with each other and against standard practice: linear
regression on levels, and on square-root and log-transformations, of costs and GLMs.
Traditional Monte Carlo simulation approaches would not be appropriate for such an exten-
sive comparison, as we are interested in a very large number of permutations of assumptions
underlying the distribution of the outcome variable. In addition, such studies are prone to
affording advantage to certain models arising from the chosen distributional assumptions
that are used for generating data. Instead, using a large administrative database consisting
of the population of English National Health Service (NHS) hospital in-patient users for the
year 2007–2008 (6164114 unique patients), we adopt a quasi-Monte-Carlo approach where
regression models are estimated on observations from one subpopulation and evaluated on
the remaining subpopulation. This enables us to evaluate the regression methods in a rigorous
and consistent manner—while ensuring that results are not driven either by overfitting to rare
but influential observations, or traditional Monte Carlo distributional assumptions—and are
generalizable to hospital in-patient services.
This paper compares and contrasts systematically these recent developments in semi-
parametric and fully parametric modelling both against each other and against standard prac-
tice. More strictly speaking, these recent developments are those that have featured in a Monte
Carlo, cross-validation or quasi-Monte-Carlo empirical comparative study. An example of a
promising method that is not compared is the extension to GLMs that was proposed by Holly
et al. (2011)—the fourth-order pseudo-maximum-likelihood method—which has been applied
to healthcare costs in Holly (2009). No comprehensive empirical comparison of these methods
is currently present in existing literature and, given the number of choices that are available for
modelling heavy-tailed, non-normal data, this study makes an important contribution towards
forming a ranking of possible approaches (for a similar study comparing propensity scoremeth-
ods, see Huber et al. (2013)). The focus of this paper is the performance of these models in terms
of predicting the conditional mean, given its importance in informing policy in healthcare and
its prominence in comparisons between econometric methods in healthcare cost regressions.
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Under certain circumstances this is justified, for instance if the policy maker has a sufficiently
large budget (Arrow and Lind, 1970). Other features of the distribution may be of interest (Van-
ness and Mullahy, 2007), especially when the policy maker has a smaller budget to allocate to
healthcare. Given our focus, we analyse bias, accuracy and goodness of fit of forecasted condi-
tional means. We find that no model performs best across all metrics of evaluation. Commonly
used approaches—linear regression on levels of costs, linear regression on log-transformed
costs, the use of gamma GLMs with log-link, and the use of the log-normal distribution—are
not among the four best performing approaches with any of our chosen metrics. Our results
indicate that models that are estimated with a square-root link perform much better than those
with log- or linear link functions. We find that linear regression with a square-root-transformed
dependent variable is the best performing model in terms of bias; the conditional density
approximation estimator (using a multinomial logit) for accuracy and the Poisson GLM with
square-root link best in terms of goodness of fit.
2. Previous comparative studies
Various studies have compared the performance of regression-based approaches to modelling
healthcare cost data, where model performance is assessed on either actual costs (i.e. costs
with an unknown true distribution) (Deb and Burgess, 2003; Veazie et al., 2003; Buntin and
Zaslavsky, 2004; Basu et al., 2006; Hill and Miller, 2010; Jones et al., 2014) or simulated costs
from an assumed distribution (Basu et al., 2004; Gilleskie and Mroz, 2004; Manning et al.,
2005). Using actual costs preserves the true empirical distribution of cost data, and all of its
complexities, whereas simulating costs provides a benchmark using the knownparameters of the
assumed distribution (classic Monte Carlo sampling) against which models can be compared.
Studies based on the classic Monte Carlo design are therefore ideally suited to assessing
whether or not regression methods can fit data when specific assumptions, and permutations
thereof, are imposedor relaxed.The complexities of the observeddistributionof healthcare costs
are such that a comprehensive comparison of modelling approaches would require an infeasibly
large number of permutations of distributional assumptions used to generate data to make a
classic Monte Carlo simulation worthwhile. Choosing a subset of the possible permutations of
assumptions is prone to cause bias in the results in favour of certain methods. A reliance on
actual data, as an alternative approach, requires large data sets so that forecasting is evaluated on
sufficient observations to reflect credibly all of the idiosyncratic features of cost data. With this
approach, however, it is difficult to assess exactly which aspect of the distribution of healthcare
costs is problematic for each method under comparison.
2.1. Studies using cross-validation approaches
With improvements in computational capacity, there have recently been several studies using
large data sets to perform quasi-Monte-Carlo comparisons across regression models for health-
care costs. Quasi-Monte-Carlo comparisons divide the data into two groups, with samples
repeatedly drawn from one group and models estimated, whereas the other group is used to
evaluate out-of-sample performance (using the coefficients from the estimated models). In this
section, we briefly review work that has implemented quasi-Monte-Carlo comparisons (Deb
and Burgess, 2003; Jones et al., 2014, 2015) as well as discuss related approaches and important
results.
Deb and Burgess (2003) examined several models to predict healthcare expenditures by
using a quasi-Monte-Carlo approach with data from the US Department of Veterans Affairs
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comprised of approximately 3 million individual records. From within these observations a
subgroup of 1.5 million individual records was used as an ‘estimation’ group and another sub-
groupof 1million records formeda ‘prediction’ group.Their results highlight a trade-off between
bias and precision, and the need for caution surrounding the use of finite mixture models at
smaller sample sizes. In terms of bias, they found that linear regression (on levels and square-
root-transformed levels of costs) performs best, whereas in terms of accuracy models based on
a gamma density have better performance. Jones et al. (2014) focused exclusively on parametric
models and suggested the use of the generalized beta of the second kindmodel as an appropriate
distribution for healthcare costs. Their quasi-Monte-Carlo design compared this distribution
together with its nested and limiting cases, including the generalized gammamodel. Using data
from hospital episode statistics split into ‘estimation’ and ‘validation’ sets, they found little
evidence that the performance of models varies with sample size, but they found variation be-
tween models in their ability to forecast mean costs, with the generalized gamma distribution
the most accurate and the beta of the second kind distribution the least biased. Jones et al.
(2015) also adopted the quasi-Monte-Carlo design but focused entirely on estimating and fore-
casting based on the cumulative distribution function and not on the conditional mean of the
distribution.
Hill andMiller (2010) and Buntin and Zaslavsky (2004) also used cross-validation techniques
so that models are estimated on samples of data and evaluated on the remaining observations.
Samples for estimation and the remaining data for evaluation differ across replications such
that, unlike a quasi-Monte-Carlo design, individuals may fall into either the estimation sample
or the validation sample at each replication. This approach is less data intensive and providing
sufficient replications should produce sufficient information in the evaluation exercise to judge
model performance. The approaches are similar in that they both replicate the sampling process
to ensure that there is no ‘lucky split’ and guard against overfitting by evaluating out of sample.
An alternative approach was considered in Veazie et al. (2003) where models were estimated
on samples of observations belonging to 1992–1993 and evaluated on 1993–1994 observations.
This is closer to the quasi-Monte-Carlo design and could potentially evaluate on data with a
different underlying generating process, since they are from a different time period. Out-of-
sample performance was also used as one metric in Basu et al. (2006) where they undertook
tests of overfitting (Copas, 1983).
2.2. Recent developments in semiparametric and fully parametric modelling
Table 1 outlines the literature comparing regression models for healthcare costs as described
above. As shown, there is no study that comprehensively and systematically evaluates all
recent developments in approaches. In addition, any synthesis of the existing literature would
be inconclusive in terms of which method is most appropriate for an application. Among the
semiparametric methods, the EEEmodel has never been directly compared in a rigorous evalu-
ation against any of the finite mixturemodels. They have both separately been compared against
standard practice (transformed dependent variable regression and GLMs) in Basu et al. (2006),
and in Hill and Miller (2010) and Deb and Burgess (2003) for EEE and finite mixture models
respectively. The conditional density approximation estimator, so far, has not been compared
with other healthcare cost regression models using actual data, although evidence fromMonte
Carlo studies suggests that it is a versatile approach (compared with standard practice meth-
ods) (Gilleskie andMroz, 2004). Jones et al. (2014) introduced the use of the flexible parametric
generalized beta of the second kind distribution with healthcare cost regressions and com-
pared this against the generalized gamma distribution, which is a limiting case of the former.
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Table 1. Models included in recent published comparative work
Method Studies using Monte Carlo Studies using cross-validation Studies using quasi-Monte-
methods Carlo methods
Veazie Buntin and Basu Hill and
Basu Gilleskie Manning et al. Zaslaysky et al. Miller Deb and Jones This
et al. and Mroz et al. (2003) (2004) (2006) (2010) Burgess et al. study
(2004) (2004) (2005) (2003) (2013)
Linear regression     
Linear regression (logarithmic)      
Linear regression (square root)    
Log-normal    
Gaussian GLM  †
Poisson   
Gamma         
EEE models   
Weibull    ‡
Generalized gamma    
Generalized beta of the second kind  
Finite mixture of gamma
distributions
 
Conditional density estimator  
†Not commonly used and problematic in estimation for our data in preliminary work.
‡A special case of generalized gamma and generalized beta of the second kind distributions which are included in our analysis.
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Given an increasing interest in modelling healthcare costs for resource allocation, risk adjust-
ment and identifying attributable treatment costs, together with the burgeoning availability of
data through administrative records, a comprehensive and systematic comparison of available
approaches is timely. The results of this comparison will have resonance beyond healthcare
costs and should be of interest to empirical applications to other right-skewed, leptokurtic or
heteroscedastic distributions such as income and wages.
3. Specification of models
Wecompare 16models that are applicable to healthcare cost data. Eachmakes different assump-
tions about the distribution of the outcome (cost) variable. Each regression uses the same vector
of covariatesXi, although the preciseway inwhich they affect the distribution varies acrossmod-
els. The covariates included are age, age2, age3, gender, genderÅage, genderÅage2, genderÅage3
and 24 morbidity markers indicating the presence or absence, coded 1 and 0 respectively, of
one or more spells with any diagnosis within the relevant subset of version 10 international
classification of diseases (ICD) codes (the 24 groupings were determined on the basis of clinical
factors and initial letter of the ICD code; see the on-line appendix A for more details). All
models specify at least one linear index of covariates X′iβ. In addition, linear regression meth-
ods with transformed outcome require assumptions surrounding the form of heteroscedasticity
(modelled as a function of Xi), to retransform predictions onto the natural cost scale (Duan,
1983). Within the GLM family, we explicitly model the mean and variance functions as some
transformation of the linear predictor (Blough et al., 1999). Fully parametric distributions, such
as the gamma and beta family of models, require an assumption about the form of the entire
distribution. In this paper, a single parameter is estimated as a function of the linear index.
Finite mixture models allow for multiple densities, each a function of the covariates in linear
form. For conditional density approximation estimator models, the empirical distribution of
costs is divided into intervals, and functions of the independent variables predict the probability
of lying within each interval.
Beginning with linear regression, we estimate three models by using ordinary least squares
(OLS): the first is on the level of costs; the second and third use a log- and square-root-
transformed dependent variable respectively (log-transformation is more commonly used in
the literature (Jones, 2011)). With these approaches, predictions are generated on a transformed
scale, and it is necessary to calculate an adjustment to retransform predictions to their natural
cost scale. This is done by applying a smearing factor, which varies according to covariates in the
presence of heteroscedasticity (Duan, 1983). Residuals from the first regression of transformed
healthcare cost against covariates are transformed by using the link function. Regressing the
transformed residual against the covariates and taking these predicted values gives each obser-
vation’s smearing factor.
Given the complications in retransformation in the presence of heteroscedasticity, researchers
more frequently use methods that estimate on the natural cost scale and explicitly model the
variance as a function of covariates. The dominant approach that achieves these aims is the
use of GLMs (Blough et al., 1999). There are two components to a GLM: the first is a link
function that relates the index of covariates to the conditional mean, and the second is a dis-
tribution function that describes the variance as a function of the conditional mean. These are
estimated simultaneously, using pseudo- or quasi-maximum-likelihood, leading to estimates
that are consistent provided that the mean function is correctly specified. Typically, the link
function in applied work takes the form of a log- or square-root function. In this paper we
consider two types of distribution function, each a power function of the conditional mean. In
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the Poisson case, the variance is proportional to the conditional mean function of covariates
and in the gamma case the variance is proportional to the conditional mean squared. Two of
the combinations of link functions and distribution families are associated with commonly used
distributions. In particular, the GLM with log-link and gamma variance is commonly applied
to healthcare costs, and the GLM with a log-link and Poisson variance is associated with the
Poisson model (see the discussion in Mullahy (1997)).
3.1. Flexible parametric models
Within the GLM and OLS approaches, much focus is placed on heteroscedasticity and the
form that it takes. Recent developments in fully parametric modelling have been made where
themodellingof highermoments, skewness andkurtosis is tackled explicitly.With this approach,
the researcher estimates the entire distribution by using maximum likelihood, which requires
that the distribution is correctly specified for consistent results. If the distribution is correctly
specified, then estimates are efficient.
3.1.1. Generalized gamma model
We estimate two models from within the gamma family, which have typically been used for
durations, but also have precedent in the healthcare costs literature (Manning et al., 2005): the
log-normal and generalized gamma distributions. Each of these is estimated, using maximum
likelihood, with a scale parameter specified as an exponential function of covariates, denoted
exp.X′iβ/. The probability density function and conditional mean for the generalized gamma
distribution are
f.yi|Xi/=
κ[κ−2{yi=exp .X′iβ/}
κ=σ]κ
−2
exp [−κ−2{yi=exp .X′iβ/}κ=σ]
σyi Γ.κ−2/
, .1/
E.yi|Xi/= exp.X′iβ/κ2σ=κ
Γ.κ−2+σ=κ/
Γ.κ−2/
.2/
where σ is a scale parameter, κ is a shape parameter and Γ.·/ is the gamma function.
When κ→ 0 the generalized gamma distribution approaches the limiting case of the log-
normal distribution, for which the probability density function and conditional mean are
f.yi|Xi/=
1
σyi
√
.2pi/
exp
[−{ln.yi/−X′iβ}2
2σ2
]
, .3/
E.yi|Xi/= exp.X′iβ/exp
(
σ2
2
)
: .4/
3.1.2. Generalized beta of the second kind distribution
We also include the generalized beta of the second kind distribution, which has yet to be com-
pared with a broad range of regression models (in Jones et al. (2014), beta-type models were
limited to comparison with gamma-type distributions). Beta-type models, like gamma-type
models, require assumptions about the form of the entire distribution. Until recently, they have
been used largely in actuarial applications, as well as for the modelling of incomes (Cummins
et al., 1990; Bordley et al., 1997). However, they have been suggested for use with healthcare
costs because of their ability tomodel heavy tails, e.g. inMullahy (2009), and they have been used
with healthcare costs in Jones et al. (2014). We include the generalized beta of the second kind
8 A. M. Jones, J. Lomas, P. T. Moore and N. Rice
distribution, since all beta-type (and gamma-type) distributions are nested or limiting cases of
this distribution. It therefore offers the greatest flexibility in terms of modelling healthcare costs
among the duration models that are used here: see for example the implied restrictions on skew-
ness and kurtosis (McDonald et al., 2013). The probability density function and conditional
mean are
f.yi/=
ay
ap−1
i
b.Xi/apB.p,q/[1+{yi=b.Xi/}a]p+q
, .5/
E.yi|Xi/=b.Xi/
{
Γ.p+1=a/Γ.q−1=a/
Γ.p/Γ.q/
}
.6/
where a is a scale parameter, p and q are shape parameters and B.p, q/=Γ.p/Γ.q/=Γ.p+q/ is
the beta function.
We parameterize the generalized beta of the second kind distributionwith the scale parameter
b as two different functions of covariates: a log-link and a square-root link.
3.2. Semiparametric methods
3.2.1. Extended estimating equations
A flexible extension of GLMs has been proposed by Basu and Rathouz (2005) and Basu et al.
(2006), which is known as the EEE model. It approximates the most appropriate link by using
a Box–Cox function, where λ=0 implies a log-link and λ=0:5 implies a square-root link:
E.yi|Xi/= .λX′iβ+1/1=λ .7/
as well as a general power function to define the variance with constant of proportionality θ1
and power θ2:
var.yi|Xi/=θ1E.yi|Xi/θ2 : .8/
Suppose that the distribution of the outcome variable is unknown but has mean and variance
nested within equations (7) and (8). An incorrectly specified GLM mean function, where com-
mon usage of GLM mean functions is limited to standard forms such as log- and square-root
link functions, yields biased and inconsistent estimates, whereas estimates from EEE models
should be unbiased, provided that the specification of regressors is correct. A well-specified
mean function combined with an incorrectly specified distribution form will be inefficient com-
pared with EEEmodels. If the distribution is known to be a specific GLM form, the EEEmodel
is less efficient than the appropriate GLM, but both are unbiased.
3.2.2. Finite mixture models
Finite mixture models have been employed in health economics to allow for heterogeneity both
in response to observed covariates and in terms of unobserved latent classes (Deb and Trivedi,
1997). Heterogeneity is modelled through a number of components, denoted C, each of which
can take a different specification of covariates (and shape parameters, where specified), written
as fj.yiXi/, and where there is a parameter for the probability of belonging to each component,
pij. The general form of the probability density function of finite mixture models is
f.yi|Xi/=
C∑
j
pijfj.yi|Xi/: .9/
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We use two gamma distribution components in our comparison. Preliminary work showed
that models with a greater number of components led to problems with convergence in estima-
tion. Empirical studies such as Deb and Trivedi (1997) provide support for the two-components
specification for healthcare use. In one of the models used, we allow for log-links in both com-
ponents (10), and in the other we allow for a square-root link (11). In both, the probability of
class membership is treated as constant for all individuals and a shape parameterαj is estimated
for each component:
fj.yi|Xi/=
y
αj
i
yi Γ.αj/exp.X
′
iβj/
αj exp
{
− yi
exp.X′iβj/
}
, .10/
fj.yi|Xi/=
y
αj
i
yi Γ.αj/.X
′
iβj/
2αj
exp
{
− yi
.X′iβj/2
}
: .11/
The conditional mean is given for the log-link specification and for the square-root link by
equations (12) and (13) respectively:
E.yi|Xi/=
C∑
j
pijαj exp .X
′
iβj/, .12/
E.yi|Xi/=
C∑
j
pijαj.X
′
iβj/
2: .13/
Unlike the models in the previous section, this approach can allow for a multimodal distri-
bution of costs. In this way, finite mixture models represent a flexible extension of parametric
models (Deb and Burgess, 2003). Using increasing numbers of components, it is theoretically
possible to fit any distribution, although in practice researchers tend to use few components
(two or three) and achieve good approximation to the distribution of interest (Heckman, 2001).
3.2.3. Conditional density approximation estimators
Finally, we use two additional models that are applications of the conditional density approxi-
mation estimator that was outlined in Gilleskie and Mroz (2004). Their method is an extension
of the two-partmodel that is frequently used to deal with zero costs, in that the range of outcome
variable is divided into Q parts (or intervals), where the mean (of observations to be used in
estimation) within interval j (j= 1, : : : ,Q) is yj and the lower and upper threshold values are
yj−1 and yj respectively (where y0 is equal to the lowest observed cost and yQ is equal to the
highest observed cost). The probability that an observation falls into interval j can be written
as
pij.Xi/=P.yj−1 yi <yj|Xi/=
∫ yj
yj−1
f.yi|Xi/dyi: .14/
The density function is then approximated by Q ‘discrete hazard rates’, defined as the prob-
ability of lying in interval j conditionally on not lying in intervals 1, : : : , j− 1 and written as
λ.j,Xi/:
λ.j,Xi/=P.yj−1 yi <yj|Xi,yi yj−1/=
∫ yj
yj−1
f.yi|Xi/dyi
1−
∫ yj−1
y0
f.yi|Xi/dyi
: .15/
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The effect of covariates can vary smoothly, or discontinuously, across intervals depending
on how the model is specified: with the most flexible case using a separate model for each
interval’s hazard rate. We assume that only the probability of lying within an interval depends
on covariates, and that the mean value of the outcome variable, for a given interval, does not
vary with covariates. The conditional mean function is therefore obtained by using
E.yi|Xi/=
Q∑
j=1
pij.Xi/yj: .16/
One of the main benefits of this approach is the flexibility that is afforded with respect to
the intervals that are used. There is flexibility in terms of the number of intervals, and where
the boundaries between them are placed, as well as the degree to which the ‘discrete hazard
rates’ are estimated separately for each interval. Within our illustration, we use 15 equally
sized intervals across all samples. Gilleskie and Mroz (2004) in their application to healthcare
costs found that between 10 and 20 intervals result in a good approximation, based on an
adjusted log-likelihood to guard against overfitting, and we found that 15 intervals resulted in
good convergence performance in preliminary work. In practice, a researcher would experiment
with different intervals and compare model performance to decide on the specification. Having
decided on the intervals to be used, we use a multinomial logit specification and an ordered
logit specification to model the probabilities of lying within each interval. This differs from the
less parametric single-logit specification that was adopted in Gilleskie and Mroz (2004), which
is more computationally demanding, and instead uses an approach similar to that of Han and
Hausman (1990). Themultinomial logit specification is similar to running a separate logitmodel
for each ‘discrete hazard rate’, whereas the ordered logit specification is analogous to allowing
the discrete hazard rate to vary discontinuously for each interval but with no discontinuity in
the effects of covariates. Fully adhering to Gilleskie and Mroz (2004) would allow the data to
determine how flexibly to estimate the discrete hazard rates; once again our implementation is
a simpler approach which approximates their method:
pij.Xi/=
exp.X′iβj/
Q∑
l=1
exp.X′iβl/
.17/
where β1=0 to normalize for estimation purposes
pij.Xi/=
exp.ψj −X′iβ/
1+ exp.ψj −X′iβ/
−pij−1 .18/
where ψj represents the estimated threshold value for each category from the ordered logit
model, pi0=0 and pi15=1−pi14, so we estimate only 14 threshold values (in our application
Q=15).
Conditional means from these models are calculated as in equation (16), where the probabili-
tiespij are calculated by using equation (17) for themultinomial logit specification and equation
(18) for the ordered logit specification.
4. Data and choice of variables
Our study uses individual level data from the English hospital episode statistics (for the financial
year 2007–2008). This data set contains information on all in-patient episodes, out-patient visits
and accident and emergency department attendances for all patients admitted to English NHS
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Table 2. Descriptive statistics for hospital costs
Statistic Results for Results for Results for
full data set estimation set validation set
N 6164114 3082057 3082057
Mean £2610 £2610 £2610
Median £1126 £1126 £1126
Standard deviation £5088 £5090 £5085
Skewness 13:03 12:94 13:13
Kurtosis 36318 347:06 379:36
Maximum £604701 £476458:3 £604701
99th percentile £19015 £19074 £18955
95th percentile £8956 £8943 £8969
90th percentile £6017 £6010 £6025
75th percentile £2722 £2721 £2722
25th percentile £610 £610 £610
10th percentile £446 £446 £446
5th percentile £407 £407 £407
1st percentile £347 £347 £347
Minimum £217 £217 £217
hospitals (Dixon et al., 2011). For our study, we exclude spells which were primarily mental or
maternity healthcare, as well as private sector spells. This data set was compiled as part of a
wider project considering the allocation ofNHS resources to primary care providers. Sincemuch
mental healthcare is undertaken in the community and with specialist providers, and hence is
not recorded in the hospital episode statistics, the data are incomplete, and also since healthcare
budgets for this type of care are constructed by using separate formulae. Maternity services
are excluded since they are unlikely to be heavily determined by morbidity characteristics, and
accordingly for the setting of healthcare budgets are determined by using alternative mecha-
nisms. The hospital episode statistics database is a large administrative data set collected by the
Health and Social Care Information Centre (now named the NHS Information Centre), with
our data set comprising 6164114 separate observations, representing the population of hospital
in-patient healthcare users for the year 2007–2008. Since data are taken from administrative
records, we have information only on users of in-patient NHS services, and therefore we can
only model strictly positive costs (0s are typically handled by a two-part specification and the
main challenge is to capture the long and heavy tail of the distribution rather than the 0s).
The cost variable that is used throughout is individual patient annual NHS hospital cost
for all spells finishing in the financial year 2007–2008. To cost utilization of in-patient NHS
facilities, tariffs from 2008–2009 (reference costs for 2005–2006, which were the basis for the
tariffs from 2008–2009, were used when 2008–2009 tariffs were unavailable) were applied to the
most expensive episode within the spell of an in-patient stay (following standard practice for
costing NHS activity). Then, for each patient, all spells within the financial year were summed.
The data are summarized in Table 2.
The challenges of modelling cost data are clearly observed in Table 2: the observed costs are
heavily right hand skewed, with themean far in excess of the median, and are highly leptokurtic.
Placement in the estimation and validation subsets was determined by a random split and as
seen in Table 2 there are only small differences in the summary statistics of the sets of observa-
tions. In particular, the ‘lumpy’ nature of the data—due to many mass points arising from the
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Fig. 1. Variance against mean for each of the 20 quantiles of the linear index of covariates: the data were
divided into 20 subsets by using the deciles of a simple linear predictor for healthcare costs with the set of
regressors introduced later; the figure plots the means and variances of actual healthcare costs for each of
these subsets, with fitted linear and quadratic trends
data-generating process—can be seen from the number of percentiles that are the same across
both subsets.
We construct a linear index of covariates (by regressing the outcome variable on the set of
covariates that we include in our regression models by using OLS) and divide the data into
quantiles according to this, to analyse conditional (on X) distributions of the outcome variable.
First, we plot the variances of each quantile against their means (Fig. 1). This gives us a sense
both of the nature of heteroscedasticity and of feasible assumptions relating these aspects of
the distribution. From Fig. 1, we can see that there is evidence against homoscedasticity (where
there would be no visible trend), and evidence for some relationship between the variance and
the mean. A similar analysis can be carried out for higher moments of the distribution, plotting
the kurtosis of each quantile against their skewness. Parametric distributions impose restrictions
on possible skewness and kurtosis: one-parameter distributions are restricted to a single point
(for example a normal distribution imposes a skewness of 0 and a kurtosis of 3), two-parameter
distributions allow for a locus of points to be estimated and distributions with three or more
parameters allow for spaces of possible skewness and kurtosis combinations. For further details
see Holly and Pentsak (2006), Pentsak (2007), McDonald et al. (2013) and Jones et al. (2015).
All the models in the quasi-Monte-Carlo comparison use a specified vector of covariates
and have at least one linear index of these. This vector mirrors the practice in the literature
regarding comparing econometric methods for healthcare costs, allowing models to control
for age (as well as age squared and age cubed), gender (interacted fully with age terms) and
morbidity characteristics (from ICDclassifications).Morbidity information is available through
the hospital episode statistics data set, adapted from the ICD version 10 chapters (WorldHealth
Organization, 2007)—see the on-line appendix A for further details. Each of the 24 morbidity
markers indicates the presence or absence, coded 1 and 0 respectively, of one or more spells with
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any diagnosis within the relevant subset of ICD version 10 chapters, during the financial year
2007–2008 (see appendix A). We do not use a fully interacted specification, since morbidity is
modelled with a separate intercept for the presence of each type of diagnosis (and not interacted
with age or gender). However, we do allow for interactions between age and its higher orders
and gender. This means that we are left with a specification that is close to those used in the
comparative literature as well as a parsimonious version of the set of covariates that are used
to model costs in person-based resource allocation in England, as in, for example, Dixon et al.
(2011). In addition, making the specification less complicated aids computation and results in
fewer models failing to converge.
5. Methodology
5.1. Quasi-Monte-Carlo design
By using the hospital episode statistics data, we have access to a large amount of observations
representing the whole population of English NHS in-patient costs. To exploit this, we use a
quasi-Monte-Carlo design similar to that of Deb and Burgess (2003). The population of obser-
vations (6164114) is randomly divided into two equally sized subpopulations: an estimation set
(3082057) and a validation set (3082057). From within the estimation set we randomly draw,
100 times with replacement, samples of size Ns (Ns ∈5000, 10000, 50000, 100000). The models
are estimated on the samples and performance then evaluated on the sample drawn from both
the estimation set and the full validation set. Using a split sample to evaluate models has prece-
dent in the comparative literature on healthcare costs; see Duan et al. (1983) andManning et al.
(1987). Fig. 2 illustrates our study design in the form of a diagram: note that the subscript m
denotes the model used, Ns the sample size used and r the replication number.
To execute this quasi-experimental design, we automate the model selection process for each
approach: for instance, with the conditional density approximation estimator, we specify a
number of bins to be estimated, a priori, rather than undergoing the investigative process that
was outlined in Gilleskie and Mroz (2004). Similarly, all models have been automated to some
extent, since we set a priori the specification of regressors (all models), the parameters that vary
with covariates (generalized gamma and generalized beta of the second kind models) and the
number of mixtures to model (finite mixture models). Our specification of regressors was based
on preliminary work, which showed that alternative specifications, including the use of a count
of the number of morbidities, give similar results, but with worse convergence performance.
5.2. Evaluation of model performance
5.2.1. Estimation sample
Researchers modelling healthcare costs will typically carry out multiple tests to establish the
reliability of their model specification. These tests are carried out in sample and help to inform
the selection of models that will then be used for predictive purposes. They are commonly
used to build the specification of the ‘right-hand side’ of the regression: the covariates used and
interactions between them. In addition, researchers workingwith healthcare costs use these tests
to establish the appropriate link function between covariates and expected conditional mean,
and other assumptions about functional form. We include results from the Pearson correlation
coefficient test, which is simple to carry out and has intuitive appeal. Results from Pregibon
link, Ramsey RESET and modified Hosmer–Lemeshow tests, in preliminary work, were found
to display the same pattern as the Pearson correlation coefficient test, but with smaller variation
in rejection rates across the different models. To carry out the Pearson correlation coefficient
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Full data set (n= 6,164,114)
Random allocation
Estimation set (n= 3,087,057) Validation set (n= 3,087,057)
Estimate models ( )
Four sample sizes (draws with
replacement)
Multiple replications at each sample size
( )
Pearson correlation test
Forecasts generated using
estimated parameters.
Full validation set used to
calculate:
MPE
MAPE
RMSE
ADMPE
Fig. 2. Diagram setting out the study design
test, residuals (computed on the raw cost scale) are regressed against predicted values of cost.
If the slope coefficient on the predicted costs is significant, then this implies a detectable linear
relationship between the residuals and the covariates, and so evidence ofmodelmisspecification.
5.2.2. Validation set
We use our models to estimate forecasted mean healthcare costs over the year for individu-
als (yˆVi = ̂E.yVi |XVi /—computed by using coefficients from models estimated on the estimation
set (for example for linear regressionE. ̂yVi |XVi /= αˆE+ βˆEXVi )—where V denotes that the obser-
vation is from the validation set, and we evaluate performance on metrics designed to reflect
the bias (mean prediction error (MPE),MPEmsr=Σ.yi− yˆi/=Ns), accuracy (mean absolute pre-
diction error (MAPE), MAPEmsr=Σ|yi− yˆi|=Ns) and goodness of fit (root-mean-square error
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(RMSE), RMSEmsr =
√
{Σ.yi− yˆi/2=Ns}) of these forecasts. The MPE can be thought of as
measuring the bias of predictions at an aggregate level, where positive and negative errors can
cancel each other out, whereas the MAPE is a measure of the accuracy of individual predic-
tions. The RMSE is similar to the MAPE in that positive and negative errors do not cancel
out; however, larger errors count for disproportionately more, since they are squared. In ad-
dition, we evaluate the variability of bias across replications (absolute deviations of the mean
prediction error (ADMPE), ADMPEmsr = |MPEmsr −ΣRr=1MPEmsr=R|). These are all evalu-
ated on the full validation set, where m denotes the model used, s the sample size used and r the
replication.
Only replications where all 16 models are successfully estimated on the sample are included
for evaluation, and model performance according to each criterion is calculated as an average
over all included replications, e.g. MPEms=ΣRr=1MPEmsr=R. All models estimated successfully
every time, except for the CDEM and EEE models. CDEM could not be estimated on two of
the 100 replicates with samples of 5000 observations. The EEE models could not be estimated
on four, four, six and four of the 100 replicates with sample sizes of 5000, 10000, 50000 and
100000 observations respectively.
To obtain a greater insight into the performance of different distributions, we evaluate
forecasted conditional means at different values of the covariates. In practice this is done by
partitioning the fitted values of costs into deciles. We assess the MPE and MAPE for deciles
of predicted costs, since there is concern that models perform with varying success at dif-
ferent points in the distribution. Models designed for heavy tails, for instance, might be ex-
pected to perform better in predicting the biggest costs. This also represents a desire to fit the
distribution of costs for different groups of observations according to their observed covari-
ates.
We combine the results that we obtain from different sample sizes Ns and attempt to find
a pattern in the way in which models perform as the sample size varies. To do this we con-
struct response surfaces (as in, for example, Deb and Burgess (2003)). These are polynomial
approximations to the relationship between the statistics of interest and the sample size of the
experiment, Ns. For our purposes, we estimate the following regression for each model and for
each metric of performance (illustrated below for the MPE):
MPEmsr =αMPEm +βMPEm
1
Ns
+uMPEmsr : .19/
We specify the relationship between theMPE and the inverse of the sample size, reflecting that
we expect reduced bias as the number of observations increases. In particular, the value ofαMPEm
represents the value of the MPE to which the model approaches asymptotically with increasing
sample size: testing whether or not this is statistically significant from 0 gives an indication of
whether the estimator is consistent. Here, uMPEmsr represents the error term from the regression.
For the metrics that cannot be negative, we use the log-function of the value as the dependent
variable. With the log-specification, differences in estimates are to be interpreted as percentage
differences, as opposed to absolute differences.
6. Results and discussion
To begin, we consider the results from the smallest samples that we draw from the estimation set
(5000 observations). Results from larger samples are analysed by way of the response surfaces
which we present later. Table 3 is a key for the labels that we use for each model in discussion of
the results.
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Table 3. Key for model labels
OLS Linear regression
LOGOLSHET Transformed linear regression (logarithmically), heteroscedastic smearing factor
SQRTOLSHET Transformed linear regression (square-root), heteroscedastic smearing factor
GLMLOGP GLM, log-link, Poisson-type family
GLMLOGG GLM, log-link, gamma-type family
GLMSQRTP GLM, square-root link, Poisson-type family
GLMSQRTG GLM, square-root link, gamma-type family
LOGNORM Log-normal
GG Generalized gamma
GB2LOG Generalized beta of the second kind, log-link
GB2SQRT Generalized beta of the second kind, square-root link
FMMLOGG Two-component finite mixture of gamma densities, log-link
FMMSQRTG Two-component finite mixture of gamma densities, square-root link
EEE EEE method
CDEM Conditional density approximation estimator (multinomial logit)
CDEO Conditional density approximation estimator (ordered logit)
6.1. Estimation sample results
We first conduct tests of misspecification across the models used. Researchers use these tests to
inform the specification of regressors, and the appropriateness of distributional assumptions, in
particular the link function. Since we use the same regressors in all models, our tests are used to
inform choices of distributional assumptions. The Pearson correlation coefficient test can detect
whether there is a linear association between the estimated residuals and estimated conditional
means, where the null hypothesis is no association. A lack of this kind of association suggests
evidence against misspecification. It is also possible, however, that the relationship between the
error and covariates is non-linear, which this test cannot detect. Linear regression estimated by
using OLS, by construction, generates residuals that are orthogonal to predicted costs, and so
the Pearson test cannot be applied to this model. The Pearson test represents a simple test that
is practically easy to implement and can be used to compare across different types of model.
Researchers may wish to consider other means to choose between models; for instance Jones
et al. (2014) compared Akaike information criterion and Bayesian information criterion scores,
AIC andBIC. These provide a useful summary of the goodness of fit of thewhole distribution on
the scale of estimation, rather than the specificationof the conditionalmean functionon the scale
of interest in the Pearson test. In this context, when comparing parametric and semiparametric
models, it is unclear how AIC and BIC could be calculated without imposing distributional
assumptions on the methods that are not fully parametric.
Table 4 shows that, according to this test, there is less evidence of misspecification when the
model is estimated by using a square-root link function compared with other possible link func-
tions, when all other distributional assumptions are the same. This is also the case in the GLM
family of models, where the link and distribution functions can be flexibly estimated by using
an EEEmodel, with results indicating that there is less evidence of misspecification with GLM-
SQRTP andGLMSQRTG than the flexible case (on average across replications with sample size
5000, the estimated λ-coefficient in the EEEmodel was 0.28 with standard deviation of 0.07, in-
dicating a link function between logarithmic and square root). Although the EEEmodel should
be better specified on the scale of estimation (following, effectively, the transformation of the de-
pendent variable), the retransformationmay lead to increased evidenceofmisspecificationon the
scale of interest (levels of costs). Introducing more flexibility in terms of the whole distribution,
generally, appears to have mixed effects on results from this test. In the case of LOGNORM
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Table 4. Percentage of tests rejected at the 5%
significance level, when all converged, 94 con-
verged replications, sample size 5000
Model Pearson test
rejection rate (%)
OLS —
LOGOLSHET 99
SQRTOLSHET 0
GLMLOGP 11
GLMLOGG 99
GLMSQRTP 0
GLMSQRTG 13
LOGNORM 95
GG 89
GB2LOG 96
GB2SQRT 85
FMMLOGG 85
FMMSQRTG 82
EEE 48
CDEM 7
CDEO 1
and GLMLOGG which are special cases of GG, there is the least evidence of misspecification
from the most complicated distribution among the three. There is also evidence of less misspec-
ification with FMMLOGG compared with GLMLOGG, which it nests. Conversely, GG and
LOGNORM are special cases of GB2LOG, for which there is the most evidence of misspecifi-
cation among these three models. Looking at the rejection rates above for FMMSQRTG and
GLMSQRTG, there is more evidence of misspecification in the more flexible case. Finally, the
results fromCDEMandCDEOare promising, with little evidence ofmisspecification compared
with other models tested. This may be because there is no retransformation process onto the
scale of interest for these models.
6.2. Validation set results
All tests in the previous section were carried out on the estimation sample. Given the practical
implementation of the models that are considered here, a researcher may be more interested in
how models perform in forecasting costs out of sample. Results based on the estimation sample
may arise from overfitting the data. Therefore, our main focus is the forecasting performance
out of sample, i.e. evaluation on the validation set.
We look first at performance of model predictions on the whole validation set. Then we con-
sider how well the models forecast for different levels of covariates throughout the distribution,
by analysing performance by decile of predicted costs. Finally, we analyse the out-of-sample
performance with increasing sample size by constructing response surfaces.
Looking at the results in Table 5, where the four best performing models in each category
(MPE, MAPE and RMSE) are in italics, it is clear that some of the most commonly used
models—OLS, LOGOLSHET, GLMLOGG and LOGNORM—do not perform well on any
metric. CDEM is among the models with top four performance in every category, illustrating
the potential advantages of this approach for analysts concerned with any of bias, accuracy
or goodness of fit. Generally, the results also indicate that a square-root link function is the
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Table 5. Results of model performance, when all converged,
sample size 5000, averaged across 94 replications
Model Bias MPE Accuracy Goodness-of-
(£) MAPE (£) fit RMSE
OLS −1:56 1833.49 4475.49
LOGOLSHET −140:53 1816.63 4960.08
SQRTOLSHET 0.11 1725.95 4432.94
GLMLOGP −1.44 1748.43 4557.19
GLMLOGG −147.33 1818.06 4984.86
GLMSQRTP 0.26 1704.77 4426.24
GLMSQRTG 46.71 1689.28 4454.25
LOGNORM 64.25 1734.10 4825.51
GG 44.60 1750.79 4754.22
GB2LOG −63:96 1796.91 4873.13
GB2SQRT 134.84 1686.48 4483.35
FMMLOGG −3:19 1758.06 4782.69
FMMSQRTG 121.80 1690.28 4477.10
EEE −42:31 1727.28 4508.03
CDEM 0.89 1683.40 4444.85
CDEO −10:13 1725.53 4474.84
most appropriate of those featured. Interestingly, the Pearson test conducted on the estimation
sample is shown here to perform well in discriminating between these competing models. This
is encouraging given its ease of implementation and interpretation.
In terms of bias, models which are mean preserving in sample also perform well out of
sample in these results. This is evidenced by the strong performance of OLS, GLMLOGP
and GLMSQRTP, with absolute levels of mean prediction error of £1:56, £1:44 and £0:26
respectively. All models with a square-root link function underpredict costs on average, whereas
some log-link function models underpredict (LOGNORM and GG) and others overpredict
on average (LOGOLSHET, GLMLOGP, GB2LOG and FMMLOGG). SQRTOLSHET and
CDEM perform best and third best respectively, and worst performing is GLMLOGG, which
overpredicts by £147:33 on average (5.64% of the population mean).
With respect to accuracy and goodness of fit, a clear message from the results is that the best
performing link function is the square-root function. The ordering of the other link functions
varies. For accuracy the flexible link function of the EEE model is next best, followed by the
log-link functionand thenOLS.For goodness of fitOLS is secondbest, followedbyEEEwhereas
the log-link model is the worst. There is variation in performance among different models with
the same link function, which we discuss next when considering the gains to increased flexibility.
In addition, CDEM performs very well according to these criteria.
First we consider the gains in using a mixture of gamma distributions, over the nested single-
gamma-distribution models. Looking at the results for GLMLOGG and FMMLOGG, the
mixture improves forecasting performance in terms of bias, accuracy and goodness of fit. This
is also observed in results from other sample sizes (see the on-line appendix B). As discussed
earlier, the gains to this increased flexibility are insufficient for results fromFMMLOGG to per-
form better than relatively simple models using a square-root link function (e.g. GLMSQRTP).
Comparing results from GLMSQRTG with those from FMMSQRTG is more complicated,
at sample size 5000; as seen in Table 5, we observe that GLMSQRTG performs better than
FMMSQRTG in all metrics. FMMSQRTG performs better than GLMSQRTG, at larger
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samples, in terms of accuracy—with FMMSQRTG the best performing model of all 16 com-
pared—but the nested single-distribution case (GB2SQRTG)performsbetter, at all sample sizes,
in terms of bias and goodness of fit (see appendix B).
Greater flexibility among the fully parametricmodels has anambiguous effect onperformance
of forecasting means. GG is a limiting case of GB2 and its performance is better across all
metrics. Conversely, LOGNORM, which is a special case of models GG and GB2, performs
best of the three in terms of accuracy, the worst in terms of bias and second in terms of goodness
of fit. Using GG or GB2LOG improves performance over special case GLMLOGG based on
the MPE, MAPE and RMSE. Once again, the best of these four models performs worse than
certain models with a square-root link function. Comparing GLMSQRTG and GB2SQRT, we
can see that not much is gained from introducing more parameters, since performance is worse
for GB2SQRT than for GLMSQRTG except in the cases of accuracy at sample sizes 5000 and
10000 (the difference is small at all sample sizes analysed).
Crucially, these results consider only performance based on the mean, whereas some of these
models can provide information on higher moments and on other features of the conditional
distribution such as tail probabilities. This is a significant qualitative advantage of parametric
models over models such as linear regression, where the models have been used to predict
probabilities of lying beyond a threshold value, e.g. tail probabilities; see Jones et al. (2014) who
found that the GG and LOGNORM distributions perform best for the threshold values they
considered. We construct graphs of bias and accuracy by decile of predicted costs. This can be
thought of as analysing the fit of models for the mean of distributions of costs conditionally on
observed variables, since each decile of predicted costs represents a group of observations with
certain values of covariates. In previous analysis, we have considered all observations as equal,
but it is possible that a policy maker prioritizes the prediction error of certain observations over
others. There is considerable interest in modelling the outcomes for high cost patients, since
these can be responsible for large proportions of overall costs. The highest costs are likely to be
found in the highest decile of predicted costs.
Fig. 3 shows that models with the same link function follow a largely similar pattern. Those,
for example, with square-root link functions underpredict in the decile of highest predicted
costs, whereas log-link models overpredict in the last decile. Results with other link functions—
OLS, EEE, CDEM and CDEO—all have different patterns. Generally, the first decile of
predicted costs from square-root models are on average underpredictions (only GB2SQRT
overpredicts in the smallest decile), which combined with the underpredicted last decile gives
them a ‘u-shaped’ line. The performance of each model varies across the deciles. SQRTOL-
SHET has a u-shaped line and, although it performs best in predicting costs on average across
all deciles, the performance for certain groups may be worse than that of other models. For
example, CDEM performs slightly worse across all 10 deciles but has a smaller range of
overpredictions and underpredictions. In terms of the highest decile of predicted costs, the
model with the lowest MPE is CDEO, underestimating on average £48:96. Generally this decile
tends to be the largest absolute MPE for models, with values as large as an average overpredic-
tion of £2211:47 in the case of GLMLOGG. Results for MAPE by decile of predicted cost are
presented in the on-line appendix B, where it is striking that the pattern across all models is very
similar.
Fig. 4 displays the response surfaces constructed to analyse how each model’s performance
varied with increasing sample size for the subset of best performing models (those in italics in
Table 5). We have already touched on this earlier when looking at results regarding accuracy be-
tween related distributions. The performance ofmost estimatedmodels varies little as the sample
sizes increase above 5000. There is some evidence that the variability of the MPE (measured by
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Fig. 4. Response surfaces for (a) log(RMSE), (b) log(MAPE), (c) log(ADMPE) and (d) MPE against sample size, constructed by evaluating performance
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using the ADMPE) reduces as the sample size increases, although this happens at a similar rate
across all models. Largely, though, the response surfaces for each model are parallel, indicating
that the relative performance of models changes little. Further, the fact that they are flat repre-
sents evidence that performance does not change for each model with increasing sample size.
The exception to this is that the performance of FMMSQRTG varies with increasing sample
size: its accuracy improves, and its bias worsens. This suggests that thismodel behaves differently
with samples as small as 5000 observations, possibly because of the number of parameters that
are required. On the whole, though, from samples of 5000 observations or more, there is little
evidence that more flexible models require more observations than less flexible models.
7. Conclusions
We have systematically evaluated the state of the art in regression models for healthcare costs,
using administrative English hospital in-patient data, employing a quasi-Monte-Carlo design to
ensure rigour and drawing conclusions based on out-of-sample forecasting. We have compared
recently adopted semiparametric and fully parametric regressionmethods that have never before
been evaluated against one another, as well as comparing with regression methods that are now
considered standard practice in modelling healthcare cost data.
Our results echo other studies, in that there is no single model that dominates in all respects:
SQRTOLSHET is the best performing model in terms of bias and CDEM for accuracy, and
in terms of goodness of fit the best performer is GLMSQRTP. This broadly corresponds to the
results from the in-sample Pearson test formodel selection, which highlights its potential use as a
simplemeans to discriminate between competingmodels.On the basis of thePearson test results,
researchers might have implemented other power transformations of the outcome in linear
regression as well as in the link functions of the GLMs. Since the EEEmodel estimated that the
appropriate link function was somewhere between a log- and square-root function (on average
0.28 over all samples of 5000observations), the researchermight have experimentedwith a cubic-
or quartic-root transformation. However, as square-root models generally outperformed EEE
models, there is no guarantee that results would have been better. Because there is no dominant
model, the policy maker must weigh up these factors in arriving at their preferred model, based
on their loss function over prediction errors. It is worth noting, however, that CDEM performs
among the best four models for all three metrics. Another striking result is that four models that
are commonly employed in regression methods for healthcare costs do not perform among the
best four of any of the threemetrics (OLS,LOGOLSHET,GLMLOGGandLOGNORM).Our
analysis by decile shows the way in which models are sensitive to the choice of link function,
with square-root link functions underpredicting in the decile of highest predicted costs, and
log-link models overpredicting in the last decile. Finally, the response surfaces indicate that, on
the whole, the more recent developments do not suffer because of the use of smaller sample
sizes (from 5000 observations).
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